Is There Any Reason to Prefer Cord Blood Instead of Adult Donors for Hematopoietic Stem Cell Transplants?

Frontiers in Medicine
Meral Beksac

Abstract

As cord blood (CB) enables rapid access and tolerance to HLA mismatches, a number of unrelated CB transplants have reached 30,000. Such transplant activity has been the result of international accreditation programs maintaining highly qualified cord blood units (CBUs) reaching more than 600,000 CBUs stored worldwide. Efforts to increase stem cell content or engraftment rate of the graft by ex vivo expansion, modulation by molecules such as fucose, prostaglandin E2 derivative, complement CD26 inhibitors, or CXCR4/CXCL12 axis have been able to accelerate engraftment speed and rate. Furthermore, introduction of reduced intensity conditioning protocols, better HLA matching, and recognition of the importance of HLA-C have improved CB transplants success by decreasing transplant-related mortality. CB progenitor/stem cell content has been compared with adult stem cells revealing higher long-term repopulating capacity compared to bone marrow-mesenchymal stromal cells and lesser oncogenic potential than progenitor-induced stem cells. This chapter summarizes the advantages and disadvantages of CB compared to adult stem cells within the context of stem cell biology and transplantation.

References

Dec 8, 2004·Best Practice & Research. Clinical Obstetrics & Gynaecology·Ian Rogers, Robert F Casper
Nov 11, 2009·Proceedings of the National Academy of Sciences of the United States of America·Jon J van RoodAndromachi Scaradavou
Aug 24, 2010·Critical Reviews in Oncology/hematology·Young-June Kim, Hal E Broxmeyer
Dec 15, 2010·Blood·Juliet N BarkerAndromachi Scaradavou
Jun 16, 2012·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Junya KandaMitchell E Horwitz
Feb 19, 2013·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Doris M PonceJuliet N Barker
Feb 19, 2013·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Shunro KaiShunichi Kato
Jan 28, 2014·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Parastoo B DahiJuliet N Barker
Mar 8, 2014·Frontiers in Immunology·Robert Danby, Vanderson Rocha
Jul 22, 2014·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Henk G M Van der ZandenPablo Rubinstein
Oct 30, 2014·The New England Journal of Medicine·John E WagnerUNKNOWN Blood and Marrow Transplant Clinical Trials Network
Oct 4, 2015·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Claudio G BrunsteinJohn E Wagner
Dec 24, 2015·Frontiers in Medicine·Rohtesh S MehtaElizabeth J Shpall

❮ Previous
Next ❯

Citations

Mar 1, 2016·Frontiers in Medicine·Meral Beksac, Pinar Yurdakul
Aug 4, 2016·Journal of Cell Communication and Signaling·Lisa Judith Crawford, Alexandra Elizabeth Irvine

❮ Previous
Next ❯

Software Mentioned

Europdonor

Related Concepts

Related Feeds

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.